Stress-induced increases in interleukin-6 and fibrinogen predict ambulatory blood pressure at 3-year follow-up

Journal of Hypertension

Volumn 23, Issue 5, 2005, Pages 1001-1007

  Brydon, Lena ^a   Steptoe, Andrew ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Ambulatory blood pressure; Fibrinogen; Interleukin 6; Psychological stress

Indexed keywords

FIBRINOGEN; INTERLEUKIN 6;

ADULT; AGE; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; BODY MASS; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MENTAL STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING; SYSTOLIC BLOOD PRESSURE;

EID: 18344387019     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000166841.57474.d0     Document Type: Article

References (38)

1. Steenland K, Fine L, Belkic K, Landsbergis P, Schnall P, Baker D, et al. Research findings linking workplace factors to CVD outcomes. Occup Med 2000; 15:7-68.
2. Hemingway H, Marmot M. Evidence based cardiology: psychosocial factors in the aetiology and prognosis of coronary heart disease. Systematic review of prospective cohort studies. BMJ 1999; 318:1460-1467.
3. Colhoun HM, Hemingway H, Poulter NR. Socio-economic status and blood pressure: an overview analysis. J Hum Hypertens 1998; 12:91-110.
4. Marmot M, Bartley M. Social class and coronary heart disease. In: Stansfield S, Marmot M (editors): Stress and the heart. London: BMJ Books; 2002, pp. 5-19.
5. Treiber FA, Kamarck T, Schneiderman N, Sheffield D, Kapuku G, Taylor T. Cardiovascular reactivity and development of preclinical and clinical disease states. Psychosom Med 2003; 65:46-62.
6. Koenig W. Fibrin(ogen) in cardiovascular disease: an update. Thromb Haemost 2003; 89:601-609.
7. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 2000; 148:209-214.
8. Chae CU, Lee RT, Rifai N, Ridker PM. Blood pressure and inflammation in apparently healthy men. Hypertension 2001; 38:399-403.
9. Fernandez-Real JM, Vayreda M, Richart C, Gutierrez C, Broch M, Vendrell J, et al. Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. J Clin Endocrinol Metab 2001; 86:1154-1159.
10. Folsom AR, Qamhieh HT, Flack JM, Hilner JE, Liu K, Howard BV, et al. Plasma fibrinogen: levels and correlates in young adults. The Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Epidemiol 1993; 138:1023-1036.
11. Makris TK, Tsoukala C, Krespi P, Hatzizacharias A, Gialeraki A, Papargyriou J, et al. Haemostasis balance disorders in patients with essential hypertension. Thromb Res 1997; 88:99-107.
12. Kiecolt-Glaser JK, Preacher KJ, MacCallum RC, Atkinson C, Malarkey WB, Glaser R. Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proc Natl Acad Sci USA 2003; 100: 9090-9095.
13. Kittel F, Leynen F, Stam M, Dramaix M, de Smet P, Mak R, et al. Job conditions and fibrinogen in 14226 Belgian workers: the Belstress study. Eur Heart J 2002; 23:1841-1848.
14. Von Kanel R, Mills PJ, Fainman C, Dimsdale JE. Effects of psychological stress and psychiatric disorders on blood coagulation and fibrinolysis: a biobehavioral pathway to coronary artery disease? Psychosom Med 2001; 63:531-544.
15. Brydon L, Edwards S, Mohamed-Ali V, Steptoe A. Socioeconomic status and stress induced increases in interleukin-6. Brain Behav Immun 2004; 18:281-290.
16. Steptoe A, Kunz-Ebrecht S, Owen N, Feldman PJ, Rumley A, Lowe GD, et al. Influence of socioeconomic status and job control on plasma fibrinogen responses to acute mental stress. Psychosom Med 2003; 65:137-144.
17. Steptoe A, Feldman PJ, Kunz S, Owen N, Willemsen G, Marmot M. Stress responsivity and socioeconomic status: a mechanism for increased cardiovascular disease risk? Eur Heart J 2002; 23:1757-1763.
18. Marmot MG, Smith GD, Stansfeld S, Patel C, North F, Head J, et al. Health inequalities among British civil servants: the Whitehall II study. Lancet 1991; 337:1387-1393.
19. Steptoe A, Kunz-Ebrecht S, Owen N, Feldman PJ, Willemsen G, Kirschbaum C, et al. Socioeconomic status and stress-related biological responses over the working day. Psychosom Med 2003; 65:461-470.
20. Steptoe A, Willemsen G. The influence of low job control on ambulatory blood pressure and perceived stress over the working day in men and women from the Whitehall II cohort. J Hypertens 2004; 22: 915-920.
21. Berardi L, Chau NP, Chanudet X, Vilar J, Larroque P. Ambulatory blood pressure monitoring: a critical review of the current methods to handle outliers. J Hypertens 1992; 10:1243-1248.
22. Humphries SE, Luong LA, Ogg MS, Hawe E, Miller GJ. The interleukin-6-174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur Heart J 2001; 22:2243-2252.
23. Lee DL, Leite R, Fleming C, Pollock JS, Webb RC, Brands MW. Hypertensive response to acute stress is attenuated in interleukin-6 knockout mice. Hypertension 2004; 44:259-263.
24. Papanicolaou DA, Petrides JS, Tsigos C, Bina S, Kalogeras KT, Wilder R, et al. Exercise stimulates interleukin-6 secretion; inhibition by glucocorticoids and correlation with catecholamines. Am J Physiol Endocrinol Metab 1996; 271:E601-E605.
25. Heinrich PC, Castell JV, Andus T. Interleukin-6 and the acute phase response. Biochem J 1990; 265:621-636.
26. Kerr R, Stirling D, Ludlam CA. Interleukin 6 and haemostasis. Br J Haematol 2001; 115:3-12.
27. Intengan HD, Schiffrin EL. Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertension 2001; 38:581-587.
28. Morimoto S, Nabata T, Koh E, Shiraishi T, Fukuo K, Imanaka S, et al. Interleukin-6 stimulates proliferation of cultured vascular smooth muscle cells independently of interleukin-1 beta. J Cardiovasc Pharmacol 1991; 17(suppl2):S117-S118.
29. Duncan MR, Berman B. Stimulation of collagen and glycosaminoglycan production in cultured human adult dermal fibroblasts by recombinant human interleukin 6. J Invest Dermatol 1991; 97:686-692.
30. Liu X, Piela-Smith TH. Fibrin(ogen)-induced expression of ICAM-1 and chemokines in human synovial fibroblasts. J Immunol 2000; 165:5255-5261.
31. Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000; 102:2165-2168.
32. Takano M, Itoh N, Yayama K, Yamano M, Ohtani R, Okamoto H. Interleukin-6 as a mediator responsible for inflammation-induced increase in plasma angiotensinogen. Biochem Pharmacol 1993; 45:201-206.
33. Touyz RM, Tabet F, Schiffrin EL. Redox-dependent signalling by angiotensin II and vascular remodelling in hypertension. Clin Exp Pharmacol Physiol 2003; 30:860-866.
34. Schorr U, Blaschke K, Turan S, Distler A, Sharma AM. Relationship between angiotensinogen, leptin and blood pressure levels in young normotensive men. J Hypertens 1998; 16:1475-1480.
35. Minuz P, Patrignani P, Gaino S, Seta F, Capone ML, Tacconelli S, et al. Determinants of platelet activation in human essential hypertension. Hypertension 2004; 43:64-70.
36. Schneider DJ, Taatjes DJ, Howard DB, Sobel BE. Increased reactivity of platelets induced by fibrinogen independent of its binding to the IIb-IIIa surface glycoprotein: a potential contributor to cardiovascular risk. J Am Coll Cardiol 1999; 33:261-266.
37. Orshal JM, Khalil RA. Reduced endothelial NO-cGMP-mediated vascular relaxation and hypertension in IL-6-infused pregnant rats. Hypertension 2004; 43:434-444.
38. Steptoe A, Marmot M. Impaired cardiovascular recovery following stress predicts 3 year increases in blood pressure. J Hypertens 2005; 23:529-536.